Their finding shows that the existence of CD4+ T cells is not adequate to propose a tumor in a milieu containing decreased CD8+ T cells and that Foxp3+ T cells might have a negative effect on the potential of CD8+ T cells for fighting against gallbladder cancer. This evidence concerns the gene CD8A and gallbladder cancer.